z-logo
Premium
In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones
Author(s) -
Minshall Richard D.,
Miyagawa Koichi,
Chadwick Christopher C.,
Novy Miles J.,
Hermsmeyer Kent
Publication year - 1998
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.12.13.1419
Subject(s) - ovariectomized rat , endocrinology , medicine , in vitro , intracellular , hormone , stimulation , vascular smooth muscle , estrogen , in vivo , protein kinase c , chemistry , biology , kinase , smooth muscle , biochemistry , microbiology and biotechnology
Susceptibility to drug‐induced coronary vasospasm in rhesus monkeys increases after removal of the ovaries and can be normalized by adding back physiological levels of estradiol‐17β (E 2 ) and/or natural progesterone (P) in vivo as reported recently by our group. Furthermore, the reactivity status (Ca 2+ and protein kinase C responses) of freshly isolated and primary culture coronary artery vascular muscle cells (VMC) mimic the intact coronary artery responses to 5‐HT + U46619. Since coronary reactivity is maintained in the isolated VMC, we hypothesized that the reactivity state inherent in the VMC was modulated directly by ovarian steroids in vitro as in the whole animal. To test this hypothesis, we treated hyperreactive VMC from ovariectomized (ovx) monkeys in vitro with E 2 or P and measured VMC reactivity to combined stimulation with 5‐HT and U46619, as determined by the amplitude and especially the duration of intracellular Ca 2+ signals, as well as protein kinase C (PKC) activation/translocation. VMC were treated for 12–96 h with 3–100 pg/ml E 2 (10–365 pM) and/or 0.3–3 ng/ml P (0.95–9.5 nM). Hyperreactive responses to the combination of 5‐HT and U46619 in untreated VMC were significantly and dose‐dependently reduced by treatment in vitro with physiological levels of either E 2 or P for at least 24 h. Both the early transient and late sustained increases in intracellular Ca 2+ and PKC translocation were blunted, and the effects of 0.2 nM E2 and 3.2 nM P were specifically antagonized by the receptor blockers ICI 182,780 (200 nM) and RU486 (15 nM), respectively. Antibodies to the estrogen receptor and progesterone receptor labeled nuclei in VMC, which were also positively labeled by a smooth muscle myosin heavy chain monoclonal antibody. These data indicate that natural ovarian steroids directly reduce hyperreactive 5‐HT and thromboxane A 2 ‐stimulated Ca 2+ and PKC responses of coronary artery VMC from surgically menopausal rhesus macaques. We hypothesize that vascular hyperreactivity, which may be a critical factor involved in the increased incidence of coronary artery vasospasm and ischemic heart disease in postmenopausal women, can be normalized by E 2 and/or P through direct actions on coronary artery vascular muscle cells.—Minshall, R. D., Miyagawa, K., Chadwick, C. C., Novy,M. J., Hermsmeyer, K. In vitro modulation of primate coronary vascular muscle cell reactivity by ovarian steroid hormones. FASEB J. 12, 1419–1429 (1998)

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here